Windlas Biotech - Quaterly Results

12 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 1870.01 millions grew by 22.49 % from Rs. 1526.72 millions.A slim rise of 11.60% was recorded in the Net profit for the quarter ended September 2024 to Rs. 156.58  millions  From Rs. 140.31 millions.Operating profit surged to 278.90 millions from the corresponding previous quarter of 219.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1870.01 1526.72 22.49 3621.54 2974.58 21.75 6309.56 5130.83 22.97
Other Income 48.41 32.40 49.41 89.74 58.64 53.04 134.68 99.65 35.15
PBIDT 278.90 219.27 27.19 529.03 416.94 26.88 915.70 702.07 30.43
Interest 11.03 2.85 287.02 15.95 5.22 205.56 11.03 7.86 40.33
PBDT 267.87 216.42 23.77 513.08 411.72 24.62 904.67 694.21 30.32
Depreciation 65.01 33.30 95.23 127.11 65.19 94.98 134.44 123.64 8.74
PBT 202.86 183.12 10.78 385.97 346.53 11.38 770.23 570.57 34.99
TAX 46.28 42.81 8.11 94.60 85.56 10.57 188.79 144.13 30.99
Deferred Tax -5.04 -0.91 453.85 -2.84 2.03 -239.90 15.35 0.63 2336.51
PAT 156.58 140.31 11.60 291.37 260.97 11.65 581.44 426.44 36.35
Equity 104.50 103.99 0.49 104.50 103.99 0.49 103.99 104.63 -0.61
PBIDTM(%) 14.91 14.36 3.84 14.61 14.02 4.22 14.51 13.68 6.06

Windlas Biotech Share Price

1031.75 5.35 (0.52%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.